Increased energy levels
News provided by Novo Nordisk Jul 01, 2026, 07:00 ET Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events including death, heart attack, or stroke in adults with obesity and heart disease a claim only Wegovy can make Since launching in January 2026, Wegovy pill has reached 3 million prescriptions * Medicare GLP-1 Bridge participation now expands patient access to authentic, FDA-approved Wegovy , including the Wegovy pill PLAINSBORO, N.J., July 1, 2026 /PRNewswire/ -- Starting today FDA-approved Wegovy (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity

Unsere Notrufsysteme eignen sich ideal fr: * Senioren und alleinlebende Personen * Menschen mit gesundheitlichen Einschrnkungen * Angehrige mit erhhtem Sicherheitsbedrfnis * aktive Menschen, die auch unterwegs abgesichert sein mchten * Personen mit Demenz oder Orientierungsschwierigkeiten Professionelle Hilfe rund um die Uhr Sobald ein Notruf ausgelst wird, stehen geschulte Ansprechpartner zur Verfgung
Ro taps Serena to Banish GLP-1 Stigmas After announcing tennis legend Serena Williams as a brand ambassador last August, direct-to-consumer healthcare company Rowhich sells GLP-1 medications including Ozempic, Wegovy, and Zepboundtapped the athlete to front its Healthier on Ro Super Bowl in-game ad
Prescribing of any treatment follows the National Institute for Health and Care Excellence (NICE) guidelines as well as other leading national best practice guidelines
But many of the biggest launches werent new SKUs